• ulation.

    Iguratimod combined with methotrexate may be considered a promising alternative for treating RA. GSK8612 Key Points • Iguratimod combination therapy produced better results in all the efficacy outcomes than methotrexate monotherapy. • Iguratimod combination therapy may be as safe as methotrexate monotherapy. • We recommend future clini…[Read more]

  • 41; 95%CI1.12-1.77) and daily/almost daily consumption in the last month (aOR = 1.56; 95CI%1.16-2.08).

    The results of this study show there is a high proportion of 16 to 18 TSSp student consumers – both prescribed and nonprescribed; it also establishes that early onset-of-use is associated with higher levels of intensive use later on.…[Read more]

  • Goldberg Skaaning became a registered member 6 months, 4 weeks ago